Scarica l'app Stockscreener
2.59
1.37%
0.035
Dopo l'orario di chiusura:
2.58
-0.010
-0.39%
Precedente Chiudi:
$2.555
Aprire:
$2.54
Volume 24 ore:
199.70K
Relative Volume:
0.58
Capitalizzazione di mercato:
$245.35M
Reddito:
$72.66M
Utile/perdita netta:
$34.86M
Rapporto P/E:
7.0765
EPS:
0.366
Flusso di cassa netto:
$-62.91M
1 W Prestazione:
-0.38%
1M Prestazione:
+8.82%
6M Prestazione:
+21.03%
1 anno Prestazione:
+83.69%
Intervallo 1D:
$2.54
$2.61
Intervallo di 1 settimana:
$2.52
$2.66
Portata 52W:
$1.295
$3.235
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.59 | 251.03M | 72.66M | 34.86M | -62.91M | 0.366 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-07 | Iniziato | Lake Street | Buy |
| 2026-01-07 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-13 | Iniziato | Oppenheimer | Outperform |
| 2022-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2020-05-26 | Ripresa | JMP Securities | Mkt Outperform |
| 2020-05-13 | Iniziato | Stifel | Buy |
| 2020-05-07 | Iniziato | SVB Leerink | Outperform |
| 2020-04-22 | Iniziato | ROTH Capital | Buy |
| 2020-03-24 | Iniziato | SunTrust | Buy |
| 2020-01-16 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-03-29 | Iniziato | Oppenheimer | Outperform |
| 2016-02-01 | Ripresa | Oppenheimer | Outperform |
| 2015-10-15 | Iniziato | FBR Capital | Outperform |
| 2015-04-23 | Ripresa | Jefferies | Buy |
| 2015-04-21 | Iniziato | Oppenheimer | Outperform |
| 2014-02-07 | Iniziato | MLV & Co | Buy |
| 2009-12-28 | Reiterato | Cantor Fitzgerald | Buy |
| 2009-07-29 | Iniziato | Cantor Fitzgerald | Buy |
Mostra tutto
Compugen Ltd Borsa (CGEN) Ultime notizie
Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance
Compugen (CGEN) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Price Reaction: Shares Finish 1.28% Up on the DayCost Structure Review - dars.gov.et
Compugen (CGEN) Dips 2.49% to $2.35, Pressure Mounts Toward Support at $2.23Price Target - vinanet.vn
Analysts Have Just Cut Their Compugen Ltd. (NASDAQ:CGEN) Revenue Estimates By 14% - simplywall.st
CGEN Q2 2026 Earnings: Loss Narrower Than Expected as EPS Surprises PositivelyMargin Expansion Trends - vinanet.vn
Compugen Ltd. (CGEN) Slides 3.6% as Biotech Stock Approaches Key $2.29 SupportBuy Signal Reports - vinanet.vn
Compugen (NASDAQ:CGEN) Share Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Compugen (CGEN) Slips 1.8% to $2.46 as Shares Hover Near Key SupportSingle Stock ETF - Vinanet
Compugen (CGEN) Gains 4.17% to $2.50 as Immuno-Oncology Stock Shows ResilienceETF NAV Deviation - vinanet.vn
Compugen (CGEN) Q2 2026 Earnings Call Transcript - AOL.com
Compugen Ltd. (CGEN) stock price, news, quote and history - Yahoo Finance Singapore
Compugen Ltd (CGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Compugen Ltd (CGEN) Stock News Today - TradingKey
Compugen Ltd. (CGEN) Rises 2.17% to $2.35: Biotech Stock Holds Key Support as Resistance at $2.47 LoomsSmall Cap Breakouts - dars.gov.et
Compugen: Better Runway Ahead Of MAIA - Seeking Alpha
FY2026 EPS Estimates for Compugen Raised by HC Wainwright - MarketBeat
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ... By GuruFocus - Investing.com Canada
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancin - GuruFocus
Compugen stock maintained at Buy by H.C. Wainwright on trial data - Investing.com South Africa
H.C. Wainwright Maintains Compugen(CGEN.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Compugen Ltd. (NASDAQ:CGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Compugen Ltd. (CGEN) Holds Steady at $2.38 as Shares Trade Within Established RangePercent Above MA - vinanet.vn
CGEN Looks 54.6% Undervalued on GF Value™ - GuruFocus
Earnings call transcript: Compugen Q2 2026 revenue misses forecast as cash runway extends - Investing.com Canada
Compugen Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Compugen Q2 Earnings Call Highlights - TradingView
CGEN: Revenue doubled and clinical programs advanced, supporting a strong outlook into 2029 - TradingView
Compugen Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Compugen Ltd Earnings Call Transcript - GuruFocus
Compugen (NASDAQ: CGEN) seeks votes on directors, pay policy and auditor - Stock Titan
COMPUGEN ($CGEN) Releases Q2 2026 Earnings - Quiver Quantitative
Compugen (NASDAQ:CGEN) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Compugen (NASDAQ: CGEN) reports H1 2026 results, cash runway into 2029 - Stock Titan
Compugen Reports Second Quarter 2026 Results - Yahoo Finance
Compugen announces annual shareholder meeting - Bitget
Compugen Q2 2026 Earnings Call Transcript - MarketBeat
Compugen (CGEN) Edges Higher at $2.35 as Biotech Sentiment SteadiesLong Term Entry Picks - dars.gov.et
Compugen Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView
CGEN Q2'26 Earnings: EPS estimate is (0.08) USD - TradingView
Earnings To Watch: Compugen Ltd (CGEN) Reports Q2 2026 Result - Yahoo Finance
Compugen (CGEN) Surges 4.24% as Biotech Sentiment Lifts Small-Cap NamesPut Flow Alert - dars.gov.et
Form 4 COMPUGEN LTD For: 30 July By Investing.com - Investing.com Nigeria
Compugen (CGEN) grants director options and RSUs with long vesting - Stock Titan
Compugen Ltd (CGEN) grants RSUs and stock options to senior executive - Stock Titan
Compugen (CGEN) director awarded 10,000 options, 7,500 RSUs - Stock Titan
Compugen Ltd. Revenue Breakdown – NASDAQ:CGEN - TradingView
Earnings Preview: Compugen to Report Financial Results Pre-market on August 03 - Moomoo
Compugen Ltd (CGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Compugen Ltd (CGEN) Income Statement - TradingKey
CGEN|Compugen Ltd|Price:2.350|Chg%:+0.015 - TradingKey
Compugen Ltd (CGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Compugen Ltd Azioni (CGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Compugen Ltd Azioni (CGEN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Levine Zurit | SVP, Business Development |
Jul 09 '26 |
Sale |
2.50 |
1,875 |
4,688 |
29,375 |
| Levine Zurit | SVP, Business Development |
Apr 24 '26 |
Option Exercise |
1.15 |
2,000 |
2,300 |
31,375 |
| Levine Zurit | SVP, Business Development |
Apr 24 '26 |
Sale |
3.20 |
2,000 |
6,400 |
29,375 |
| Ophir Eran | President and CEO |
Apr 24 '26 |
Option Exercise |
0.83 |
5,000 |
4,146 |
16,375 |
| Ophir Eran | President and CEO |
Apr 24 '26 |
Sale |
3.20 |
5,000 |
16,000 |
11,375 |
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):